Navigation Links
Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software
Date:10/14/2009

Latest release of popular clinical trials software adds new features, enhanced performance.

Waltham, MA (PRWEB) October 14, 2009 -- Akaza Research is pleased to announce the release of OpenClinica 3.0, the newest version of the world's most popular open source electronic data capture (EDC) software for clinical trials. This latest production release marks a significant milestone for open source software in the clinical trials field, adding a host of new capabilities designed to further accelerate the adoption of open source into mainstream research.

"OpenClinica 3.0 brings a new level of simplicity to EDC," said Cal Collins, CEO of Akaza Research. "We have added powerful new capabilities and made them accessible through an intelligent, task-oriented user interface. Each user can be confident that OpenClinica will make them more productive at their job."

Some of the enhancements in OpenClinica 3.0 include:

- Streamlined user interface that simplifies site usage
- Study progress dashboard
- Improved query workflows, with notifications, chain of custody, and task management
- Source data verification workspace
- Faster page load time
- Dedicated Study Build module
- Improved control over significant digits in eCRF data items
- Job scheduler
- Web services interface to allow for programmatic data interchange with other systems

"This release illustrates how an open source community can produce superior software," said Paul Galvin, OpenClinica Project Manager at Akaza Research. "Contributions and input from both industry and academic users and developers across the globe has allowed us to release the most feature rich, thoroughly tested, and high performance version of OpenClinica to-date."

As open source software, OpenClinica is free for organizations to use and modify. The software may be downloaded from http://www.openclinica.org with installation scripts as well as upgrade scripts for users utilizing the previous version of OpenClinica. A public demonstration instance is available at http://demo2.openclinica.org/OpenClinica-3.0.

OpenClinica Enterprise, the commercial distribution of OpenClinica, is available through Akaza Research. More information see http://www.openclinica.org/Enterprise.

Webinar Presentation of OpenClinica 3.0

Akaza Research will be conducting a webinar presentation of OpenClinica 3.0 on October 28, 2009 to demonstrate the new product and answer questions form the community. Registration for this event is free.

Wednesday, October 28 @ 9:30 -11:00 Eastern Time U.S. (GMT -4:00) - Register Here
Wednesday, October 28 @ 18:00 - 19:30 Eastern Time U.S. (GMT -4:00) - Register Here

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical trial data management. OpenClinica facilitates data collection via electronic case report forms (eCRFs), and provides tools for data management and productive monitoring of clinical trials. OpenClinica supports CDISC standards and is designed to be compliant with industry and government regulations and guidelines such as 21 CFR Part 11, GCP, and HIPAA. OpenClinica is professionally supported by Akaza Research and has a worldwide open source community of over 7,500 users and developers. OpenClinica is freely available for download and use from http://www.openclinica.org.


About Akaza Research®

Akaza Research provides professional open source software for clinical trials. The company's flagship product, OpenClinica, provides electronic data capture (EDC) and clinical data management (CDM) capabilities for clinical research. By bringing open source software into the mainstream of clinical research, Akaza is able to provide a cost effective technology solution that is more flexible and transparent than proprietary, closed systems. Akaza Research provides a full spectrum of OpenClinica-related products and services to a worldwide customer base through its OpenClinica EnterpriseTM solution. For more information about Akaza Research, see http://www.akazaresearch.com.

###

Read the full story at http://www.prweb.com/releases/clinical_trials_software/electronic_data_capture/prweb3041334.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. New Survey Shows Devastating Impact of Rheumatoid Arthritis Pain on Intimate Relations
2. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
3. Plastics that convert light to electricity could have a big impact
4. Novel method predicts impact of a covert anthrax release
5. Novel method predicts impact of a covert anthrax release
6. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
7. World Micromachine Summit highlights technologies impacting energy and the environment
8. Event Alert: SPL R4 Compliance and its Impact on Regulatory Submission Processes
9. What Will Be the Impact of Programs of Study?
10. PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
11. Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software 
(Date:6/23/2016)... ... 23, 2016 , ... Supplyframe, the Industry Network for electronics ... Lab . Located in Pasadena, Calif., the Design Lab’s mission is to bring ... designed, built and brought to market. , The Design Lab is Supplyframe’s physical ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a ... designed, tuned and optimized exclusively for Okuma CNC machining centers at The International ... a collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
Breaking Biology News(10 mins):